Filing Details

Accession Number:
0001209191-19-045638
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-12 19:24:43
Reporting Period:
2019-08-12
Accepted Time:
2019-08-12 19:24:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286710 Francis Cano C/o Dynavax Technologies Corporation
2100 Powell Street, Suite 900
Emeryville CA 94608
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-12 16,667 $3.00 16,667 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2019-08-12 4,167 $0.00 4,167 $4.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,167 2022-02-12 No 4 P Direct
Footnotes
  1. Immediate